Letter to the EditorH63/H63D genotype and the H63D allele are associated in patients with hyperferritinemia to the development of metabolic syndrome
Section snippets
CRediT authorship contribution statement
Agustin Castiella: Writing - original draft. Iratxe Urreta: Writing - original draft. Eva Zapata: Writing - original draft. M Dolores de Juan: Writing - original draft. Jose I. Emparanza: Writing - original draft.
Declaration of Competing Interest
None.
Funding
No funding.
References (8)
- et al.
Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country
Ann Hepatol
(2015) - et al.
How should hyperferritinemia be investigated and managed?
Eur J Intern Med
(2016) - et al.
Diagnostic algorithm for high iron overload: results from a prospective study of 312 patients with hyperferritinemia
J Hepatol
(2016) - et al.
Liver iron concentraion is not raised in patients with dysmetabolic hyperferritinemia
Ann Hepatol
(2016)
Cited by (4)
H63D Syndrome: data and facts
2021, Research SquarePrevalence of narcolepsy in patients with H63D syndrome
2021, Research Square
- 1
Members of the Burnia Group: Hospital de Mendaro: Leire Zubiaurre, Eva Zapata, Agustín Castiella, Arantxa Iribarren; Hospital Universitario Donostia: Leire Zubiaurre, Eva Zapata, Agustín Castiella, Usua Mendarte, Luis Bujanda, Nerea Muro, Begoña Ibarra, M.Dolores de Juan, Iratxe Urreta, Jose I. Emparanza; Osatek Donostia: Jose M.Alústiza, Emma Salvador; Hospital de Mondragón: Pedro Otazua, Aitor de Juan; Hospital de Galdakao: Garazi Letamendi; Hospital de Cruces: Beatriz Arrizabalaga; Hospital del Bidasoa: Maria Luisa Rincón.